A common treatment for anemia is administration of recombinant erythropoietin, a hormone that stimulates the production of rbc precursors by the bone marrow. Unfortunately, many patients with anemia do not respond to treatment with Epo. However, a new study in mice has indicated that the protein Gas6 might have valuable therapeutic potential for the treatment of individuals with anemia who fail to respond to treatment with Epo.